This legislation aims to enhance the Medicare program's payment structure for skin substitute products used in wound care, ensuring these essential treatments are adequately covered and reimbursed. By improving access to these products, the bill seeks to support patients who require effective wound care solutions. Key provisions include the addition of skin substitute products to Medicare's list of covered items, with a set reimbursement rate of $457 per square centimeter starting January 1, 2027, through December 31, 2030.